135 related articles for article (PubMed ID: 391150)
1. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
Alvarez JS; Regueiro B; Garrido MJ
Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
[TBL] [Abstract][Full Text] [Related]
2. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
Markowitz SM; Sibilla DJ
Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance patterns of clinical isolates of Serratia marcescens.
Cooksey RC; Bannister ER; Farrar WE
Antimicrob Agents Chemother; 1975 Apr; 7(4):396-9. PubMed ID: 1096799
[TBL] [Abstract][Full Text] [Related]
4. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
Langstaff D; Schueler S; Righter J
J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
[TBL] [Abstract][Full Text] [Related]
5. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
Schassan HH
Infection; 1976; 4(2):35-41. PubMed ID: 789246
[TBL] [Abstract][Full Text] [Related]
6. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
Meyer RD; Lewis RP; Halter J; White M
Lancet; 1976 Mar; 1(7959):580-3. PubMed ID: 55850
[TBL] [Abstract][Full Text] [Related]
7. Gentamicin-resistant Serratia marcescens endophthalmitis.
Gammon JA; Schwab I; Joseph P
Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
[TBL] [Abstract][Full Text] [Related]
8. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
Filloy L; Serrano D; Borjas E
Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
Igari J; Oguri T; Kosakai N
Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
Ding MJ; Sung SJ
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
[TBL] [Abstract][Full Text] [Related]
12. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents.
Sofianou D; Proya E; Kondodimou A
J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
Traub WH
Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
[TBL] [Abstract][Full Text] [Related]
14. Nonspecific aminoglycoside cross-resistance of Serratia marcescens.
Traub WH; Fukushima PI
Chemotherapy; 1979; 25(4):204-13. PubMed ID: 378576
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae.
Lewis RP; Meyer RD; Kraus LL
Antimicrob Agents Chemother; 1976 May; 9(5):780-6. PubMed ID: 949175
[TBL] [Abstract][Full Text] [Related]
16. Serratia marcescens: a study of the sensitivity of British isolates to antibacterial agents and their combinations.
Gray J; McGhie D; Ball AP
J Antimicrob Chemother; 1978 Nov; 4(6):551-9. PubMed ID: 361679
[No Abstract] [Full Text] [Related]
17. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
Sakai S; Kumamoto Y
Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
[No Abstract] [Full Text] [Related]
18. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Maslow MJ; Simberkoff MS; Rahal JJ
J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
[TBL] [Abstract][Full Text] [Related]
19. Serratia marcescens as a postoperative pathogen.
Williams TW; Sailer JE; Viroslav J; Knight V; Glasgow N; Moreland N
Am J Surg; 1971 Jul; 122(1):64-9. PubMed ID: 4326385
[No Abstract] [Full Text] [Related]
20. Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens.
John JF; McNeill WF; Price KE; Kresel PA
Antimicrob Agents Chemother; 1982 Apr; 21(4):587-91. PubMed ID: 7044303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
